ProShare Advisors’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-87,108
| Closed | -$4.04M | – | 1720 |
|
|
2019
Q2 | $4.04M | Sell |
87,108
-9,988
| -10% | -$463K | 0.02% | 450 |
|
|
2019
Q1 | $2.37M | Buy |
97,096
+3,143
| +3% | +$76.6K | 0.01% | 564 |
|
|
2018
Q4 | $1.34M | Sell |
93,953
-17,671
| -16% | -$252K | 0.01% | 651 |
|
|
2018
Q3 | $1.7M | Sell |
111,624
-3,754
| -3% | -$57.1K | 0.01% | 648 |
|
|
2018
Q2 | $1.94M | Sell |
115,378
-6,070
| -5% | -$102K | 0.01% | 631 |
|
|
2018
Q1 | $1.98M | Sell |
121,448
-14,253
| -11% | -$233K | 0.01% | 618 |
|
|
2017
Q4 | $1.74M | Buy |
135,701
+27,278
| +25% | +$349K | 0.01% | 649 |
|
|
2017
Q3 | $1.33M | Buy |
108,423
+5,503
| +5% | +$67.7K | 0.01% | 665 |
|
|
2017
Q2 | $861K | Sell |
102,920
-6,547
| -6% | -$54.8K | 0.01% | 774 |
|
|
2017
Q1 | $979K | Sell |
109,467
-28,764
| -21% | -$257K | 0.01% | 755 |
|
|
2016
Q4 | $1.22M | Buy |
138,231
+32,582
| +31% | +$286K | 0.01% | 693 |
|
|
2016
Q3 | $713K | Sell |
105,649
-18,794
| -15% | -$127K | 0.01% | 802 |
|
|
2016
Q2 | $443K | Buy |
124,443
+1,080
| +0.9% | +$3.85K | 0.01% | 1030 |
|
|
2016
Q1 | $364K | Sell |
123,363
-11,865
| -9% | -$35K | 0.01% | 1127 |
|
|
2015
Q4 | $571K | Buy |
135,228
+13,337
| +11% | +$56.3K | 0.01% | 984 |
|
|
2015
Q3 | $556K | Sell |
121,891
-8,620
| -7% | -$39.3K | 0.01% | 902 |
|
|
2015
Q2 | $941K | Sell |
130,511
-9,032
| -6% | -$65.1K | 0.01% | 803 |
|
|
2015
Q1 | $1.03M | Buy |
139,543
+25,199
| +22% | +$186K | 0.01% | 833 |
|
|
2014
Q4 | $541K | Sell |
114,344
-3,511
| -3% | -$16.6K | 0.01% | 1159 |
|
|
2014
Q3 | $421K | Sell |
117,855
-19,882
| -14% | -$71K | 0.01% | 1516 |
|
|
2014
Q2 | $628K | Sell |
137,737
-83,525
| -38% | -$381K | 0.01% | 1435 |
|
|
2014
Q1 | $1.04M | Buy |
221,262
+157,763
| +248% | +$742K | 0.01% | 1279 |
|
|
2013
Q4 | $318K | Sell |
63,499
-51,367
| -45% | -$257K | ﹤0.01% | 1142 |
|
|
2013
Q3 | $714K | Buy |
114,866
+17,010
| +17% | +$106K | 0.02% | 1143 |
|
|
2013
Q2 | $444K | Buy |
+97,856
| New | +$444K | 0.01% | 1423 |
|